Velan Capital Investment Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Velan Capital Investment Management’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-78,125	Closed	-$188K	–	23
2024 Q2	$188K	Hold	78,125	–	–	0.11%	17
2024 Q1	$385K	Buy	+78,125	New	+$391K	0.17%	21
2023 Q4	–	Sell	-78,125	Closed	-$1.18M	–	33
2023 Q3	$1.18M	Buy	+78,125	New	+$1.43M	0.95%	20

Other funds holding ASLN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Velan Capital Investment Management's ASLN Position: Q3 2024 in Review

Velan Capital Investment Management sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 78,125 shares — an estimated $188K sold.

Velan Capital Investment Management first reported a position in ASLN in Q3 2023 and held it in 3 quarters. The position peaked at $1.18M in Q3 2023. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.

Velan Capital Investment Management reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
Velan Capital Investment Management sold 78,125 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $188K.
Velan Capital Investment Management first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q3 2023 and held it in 3 quarters.
Velan Capital Investment Management's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $1.18M in Q3 2023.
1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.

Based on Velan Capital Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.